1-Piperazineacetamide,4-(2-hydroxyethyl)-(7CI)
- $133 - $240
- Product name: 1-Piperazineacetamide,4-(2-hydroxyethyl)-(7CI)
- CAS: 90228-11-8
- MF: C8H17N3O2
- MW: 187.24
- EINECS:
- MDL Number:MFCD11505330
- Synonyms:1-Piperazineacetamide,4-(2-hydroxyethyl)-(7CI);2-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]ACETAMIDE;2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamide(SALTDATA: HCl);2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamide;2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamide Hydrochloride;1-Piperazineacetamide, 4-(2-hydroxyethyl)-
3 prices
Selected condition:
Brand
- ChemBridge Corporation
- TRC
Package
- 1g
- 5G
- 10g
- ManufacturerChemBridge Corporation
- Product numberBB-4033790
- Product description2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamidehydrochloride 95%
- Packaging10g
- Price$224
- Updated2021-12-16
- Buy
- ManufacturerChemBridge Corporation
- Product numberBB-4033790
- Product description2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamidehydrochloride 95%
- Packaging5G
- Price$133
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB444475
- Product description2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamideHydrochloride
- Packaging1g
- Price$240
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
ChemBridge Corporation | BB-4033790 | 2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamidehydrochloride 95% | 10g | $224 | 2021-12-16 | Buy |
ChemBridge Corporation | BB-4033790 | 2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamidehydrochloride 95% | 5G | $133 | 2021-12-16 | Buy |
TRC | B444475 | 2-[4-(2-hydroxyethyl)-1-piperazinyl]acetamideHydrochloride | 1g | $240 | 2021-12-16 | Buy |
Properties
Melting point :92-93 °C
Boiling point :397.0±32.0 °C(Predicted)
Density :1.155±0.06 g/cm3(Predicted)
pka :14.96±0.10(Predicted)
Boiling point :397.0±32.0 °C(Predicted)
Density :1.155±0.06 g/cm3(Predicted)
pka :14.96±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|